Overview

Hormone therapy for prostate cancer is treatment to stop the male hormone testosterone from reaching prostate cancer cells in your body. Hormone therapy for prostate cancer is also known as androgen deprivation therapy.

Most prostate cancer cells rely on testosterone to help them grow. Hormone therapy cuts off the supply of testosterone or stops testosterone from reaching the cancer cells, causing cancer cells to die or to grow more slowly.

Hormone therapy for prostate cancer may involve medications or possibly surgery to remove the testicles.

April 26, 2016
References
  1. Wein AJ, et al., eds. Diagnosis and staging of prostate cancer. In: Campbell-Walsh Urology. 11th ed. Philadelphia, Pa.: Elsevier; 2016. http://www.clinicalkey.com. Accessed Jan. 25, 2016.
  2. Dawson NA. Overview of the treatment of disseminated prostate cancer. http://www.uptodate.com/home. Accessed Jan. 25, 2016.
  3. Niederhuber JE, et al., eds. Prostate cancer. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed Jan. 26, 2016.
  4. Lee RJ, et al. Initial systemic therapy for castration sensitive prostate cancer. http://www.uptodate.com/home. Accessed Jan. 25, 2016.
  5. Roach M. Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer. Cancer. 2014;120:1620.
  6. Smith MR, et al. Side effects of androgen deprivation therapy. http://www.uptodate.com/home. Accessed Jan. 25, 2016.
  7. Dawson NA. Secondary endocrine therapies for castration resistant prostate cancer. http://www.uptodate.com/home. Accessed Jan. 25, 2016.
  8. Steele GS, et al. Radical inguinal orchiectomy for testicular germ cell cancers. http://www.uptodate.com/home. Accessed Jan. 25, 2016.